- Home
- MIND vs UNCY Comparison
MIND vs UNCY Comparison
Compare MIND & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- UNCY
- Stock Information
- Founded
- MIND 1987
- UNCY 2016
- Country
- MIND United States
- UNCY United States
- Employees
- MIND N/A
- UNCY N/A
- Industry
- MIND Industrial Machinery/Components
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- MIND Industrials
- UNCY Health Care
- Exchange
- MIND Nasdaq
- UNCY Nasdaq
- Market Cap
- MIND 30.7M
- UNCY 31.9M
- IPO Year
- MIND 1994
- UNCY 2021
- Fundamental
- Price
- MIND $6.86
- UNCY $0.66
- Analyst Decision
- MIND
- UNCY Strong Buy
- Analyst Count
- MIND 0
- UNCY 4
- Target Price
- MIND N/A
- UNCY $5.50
- AVG Volume (30 Days)
- MIND 455.8K
- UNCY 1.5M
- Earning Date
- MIND 12-10-2024
- UNCY 11-13-2024
- Dividend Yield
- MIND N/A
- UNCY N/A
- EPS Growth
- MIND N/A
- UNCY N/A
- EPS
- MIND 6.61
- UNCY N/A
- Revenue
- MIND $45,197,000.00
- UNCY N/A
- Revenue This Year
- MIND $22.98
- UNCY N/A
- Revenue Next Year
- MIND $10.18
- UNCY N/A
- P/E Ratio
- MIND $0.97
- UNCY N/A
- Revenue Growth
- MIND 41.23
- UNCY N/A
- 52 Week Low
- MIND $3.05
- UNCY $0.20
- 52 Week High
- MIND $7.39
- UNCY $1.82
- Technical
- Relative Strength Index (RSI)
- MIND 91.35
- UNCY 52.04
- Support Level
- MIND $5.55
- UNCY $0.62
- Resistance Level
- MIND $6.47
- UNCY $0.87
- Average True Range (ATR)
- MIND 0.43
- UNCY 0.08
- MACD
- MIND 0.34
- UNCY -0.01
- Stochastic Oscillator
- MIND 95.33
- UNCY 15.45
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.